Synthetic pyrethroid insecticide-Deltamethrin is widely used throughout the world as pesticide in agriculture, animal husbandry, to control pests at home, to protect food items and in vector control as disease prophylaxis measure. Its mechanism of dermal toxicity, neurotoxicity, pulmonary toxicity, and carcinogenic properties is well known. Apart from causing multiorgan toxicity, it is also toxic to the immune system
(Kumar et al., 2014). In this study Bone marrow stem cells, from the higher animal model
caprus was isolated and expanded
in vitro. To test the difference in the effect of deltamethrin on CD 45+ cells at different concentrations of the pesticide,
in vitro stem cell culture system from bone marrow with HSC and MSC was used. Progenitor cells proliferation was checked on alternate days. Changes in the morphology of the cells were recorded. Fig 1 represents the growth of the SCs without the treatment of deltamethrin; the growth of cells is apparently normal and healthy. The control cells spread and grow in the media with normal morphology. While under the treatment of deltamethrin (from 200 µM or 0.2 mM to 1 M), there was an abnormality in the morphology of the BMSCs, and cells showed apoptotic changes at 1 mM concentration. There was a decrease in the number of viable cells with an increase in the concentration of deltamethrin. This may be because more concentration of deltamethrin means number of active sites it binds to is higher and quicker the apoptosis.
Liu et al., (2014) showed that deltamethrin induced concentration-dependent influx of Ca 2+ into the cell this affects the cellular response and causes apoptosis (Fig 3 and 4).
There was also a significant difference in the proliferative ability between the cells grown at different time points. There was a decrease in the number of viable cells with increasing time of exposure to deltamethrin. This signifies that the longer the time of exposure, the more toxic the compound is to the system, this is more prominent at higher concentrations of the pesticide. While at the lower concentration of 0.2mM concentration, there is an increase of cell death (toxicity) by 8% from day 1 to day 7, at a higher concentration of 1mM, there is an increase of cell death (toxicity) by 19% from day 1 to day 7.
Kumar et al (2014) study indicated that the cells go through apoptosis because deltamethrin occupies and binds on the binding domains of the immune receptors present on the surface of these cells, causing the normal immune pathways to become dysfunctional. Therefore the cells undergo apoptosis.
Hossain and Richardson (2011), pyrethroid pesticide deltamethrin has been demonstrated the ability of pyrethroid pesticide deltamethrin to cause apoptosis both
in vitro and
in vivo. However, the molecular pathways leading to deltamethrin-induced apoptosis has not been established. To identify these pathways, SK-N-AS neuroblastoma cells were exposed to deltamethrin (100 nM-5 µM) for 24-48 hrs. Deltamethrin produced a time and dose-dependent increase (21-121%) in DNA fragmentation, an indicator of apoptosis. Data demonstrated that the initiation of DNA fragmentation resulted from interaction of deltamethrin with Na+ channels and consequent calcium influx, as tetrodotoxin and the intracellular Ca2+ chelator BAPTA. The present study results correlated to the apoptosis effect and analysed the less explored predicted effects of deltamethrin on blood stem cells through CD45 receptor and virtual effects on cultured cells. iGEMDOCK 2.1 software was used to dock CD45 receptors with DLM. The binding mode indicates that the bound ligand and the active site of CD45 had a good binding score of -68.04 and formed the five H bonds with the amino acids residues (HIS 418, ASN 419, ASP 436, LYS 437, ASN 438) of CD45 (Fig 2). Whereas, DLM showed a docking score of 78.78 and formed hydrogen bond with ASN 419, ASP 436 amino acid residues of CD45 (Table 1). Deltamethrin has a higher docking score as compared to the reference ligand, this might mean that deltamethrin might take the place of a molecule or a ligand that normally binds to CD45 towards immune pathway. NAG (N-acetyl glucosamine) enhances N-glycan branching promotes CTLA-4 surface expression and inhibits adoptive transfer EAE
(Grigorian et al., 2007). In this pathway NAG interacts with T cell receptor (TCR) and CD45
Grigorian, et al., (2011). This might affect the overall immune response of the cell.